Dysgeusia increases the risk for death and other side effects during antineoplastic systemic treatment for solid tumors: a cross-sectional study
CONCLUSIONS: Dysgeusia during CT increases the risk of other adverse effects and negatively impacts prognosis.PMID:38615256 | DOI:10.4317/medoral.26389
Source: Medicina Oral, Patologia Oral y Cirugia Bucal - Category: ENT & OMF Authors: P-G Silva G-A Barreto A-C Carlos M-M Borges C-E Malta J-V Barbosa A-A Crispim S-F Jua çaba L-F Gonzaga-Silva Source Type: research
More News: Anorexia | Cancer | Cancer & Oncology | Chemotherapy | Constipation | Eating Disorders & Weight Management | Electronic Health Records (EHR) | ENT & OMF | Gastroenterology | Information Technology | Malta Health | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Obesity | Oral Cancer | Study